Capecitabine/Tesetaxel Versus Capecitabine/Placebo as Second-line Therapy for Gastric Cancer

NCT01573468 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

580

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastric Carcinoma

Interventions

DRUG: Tesetaxel
DRUG: Placebo
DRUG: Capecitabine

Sponsor

Genta Incorporated